These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2325830)

  • 1. Effects of the enkephalinase inhibitor SCH 34826 on the sleep-waking cycle and EEG activity in the rat.
    Trampus M; Conti A; Marzanatti M; Monopoli A; Ongini E
    Neuropharmacology; 1990 Mar; 29(3):199-205. PubMed ID: 2325830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of orally active enkephalinase inhibitors on morphine withdrawal syndrome.
    Dzoljic MR; Bokszanska A; Korenhof AM; Kaplan CD; Dzoljic M; Rupreht J; Zijlstra FJ; Brinkman EC; Cappendijk SL
    Neuroreport; 1992 Jul; 3(7):637-40. PubMed ID: 1421123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antinociceptive effects of the enkephalinase inhibitor, SCH 34826, in the snail, Cepaea nemoralis.
    Saksida LM; Galea LA; Kavaliers M
    Peptides; 1993; 14(4):763-5. PubMed ID: 8234022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of SCH 34826, an orally active enkephalinase inhibitor analgesic.
    Chipkin RE; Berger JG; Billard W; Iorio LC; Chapman R; Barnett A
    J Pharmacol Exp Ther; 1988 Jun; 245(3):829-38. PubMed ID: 3164388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The D1 dopamine receptor antagonist SCH 23390 enhances REM sleep in the rat.
    Trampus M; Ongini E
    Neuropharmacology; 1990 Oct; 29(10):889-93. PubMed ID: 2147740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The GABAA receptor agonist THIP alters the EEG in waking and sleep of mice.
    Vyazovskiy VV; Kopp C; Bösch G; Tobler I
    Neuropharmacology; 2005 Apr; 48(5):617-26. PubMed ID: 15814097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial natriuretic factor-potentiating and antihypertensive activity of SCH 34826. An orally active neutral metalloendopeptidase inhibitor.
    Sybertz EJ; Chiu PJ; Vemulapalli S; Watkins R; Haslanger MF
    Hypertension; 1990 Feb; 15(2):152-61. PubMed ID: 2154404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in the antinociceptive effects of the enkephalinase inhibitor, SCH 34826.
    Kavaliers M; Innes DG
    Pharmacol Biochem Behav; 1993 Dec; 46(4):777-80. PubMed ID: 8309954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of Purkinje cell response to glutamate during the sleep-waking cycle.
    Andre P; Arrighi P
    Neuroscience; 2001; 105(3):731-46. PubMed ID: 11516837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the selective dopamine D-2 receptor agonist, quinpirole on sleep and wakefulness in the rat.
    Monti JM; Jantos H; Fernández M
    Eur J Pharmacol; 1989 Oct; 169(1):61-6. PubMed ID: 2574689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analgesic and acute central nervous system side effects of the intravenously administered enkephalinase inhibitor SCH 32615.
    Chipkin RE; Coffin VL
    Pharmacol Biochem Behav; 1991 Jan; 38(1):21-7. PubMed ID: 2017447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for activation by enkephalin-like opioid peptides after cold water swim stress.
    Parsons CG; Herz A
    J Pharmacol Exp Ther; 1990 Nov; 255(2):795-802. PubMed ID: 2173759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the effect of SCH-34826 and thiorphan on [Met5]enkephalin levels and release in rat spinal cord.
    Yaksh TL; Chipkin RE
    Eur J Pharmacol; 1989 Aug; 167(3):367-73. PubMed ID: 2806377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the 5-HT2 antagonist ritanserin on sleep-walking cycle in the rat.
    Silhol S; Glin L; Gottesmann C
    Pharmacol Biochem Behav; 1992 Jan; 41(1):241-3. PubMed ID: 1539075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep/waking and EEG power spectrum effects of a nonselective serotonin (5-HT) antagonist and a selective 5-HT reuptake inhibitor given alone and in combination.
    Bjorvatn B; Bjørkum AA; Neckelmann D; Ursin R
    Sleep; 1995 Jul; 18(6):451-62. PubMed ID: 7481417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of remoxipride, a dopamine D-2 antagonist antipsychotic, on sleep-waking patterns and EEG activity in rats and rabbits.
    Ongini E; Bo P; Dionisotti S; Trampus M; Savoldi F
    Psychopharmacology (Berl); 1992; 107(2-3):236-42. PubMed ID: 1352054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-response effects of 8-cyclopropyltheophylline on sleep and wakefulness in rats.
    Radulovacki M; Virus RM
    Psychopharmacology (Berl); 1988; 94(3):417-20. PubMed ID: 2895941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of methylmercury chloride on sleep-waking rhythms in rats.
    Arito H; Hara N; Torii S
    Toxicology; 1983 Nov; 28(4):335-45. PubMed ID: 6648981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphine effects on human REM state, waking state and NREM sleep.
    Kay DC; Eisenstein RB; Jasinski DR
    Psychopharmacologia; 1969; 14(5):404-16. PubMed ID: 4310918
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic profiles of morphine-induced EEG, EEG power spectra, and behavior in two inbred rat strains.
    Mayo-Michelson L; Young GA
    Brain Res Bull; 1993; 30(1-2):79-84. PubMed ID: 8420638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.